A phase 2 dose‐finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis-Reference-Cited by-同舟云学术

A phase 2 dose‐finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis

Published:2021-12-23 Issue: Volume: Page:
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Yurdaydin Cihan¹²³^ORCID,Keskin Onur¹,Yurdcu Esra²,Çalişkan Aysun¹,Önem Soner¹,Karakaya Fatih¹,Kalkan Çağdaş¹,Karatayli Ersin²⁴,Karatayli Senem²⁴,Choong Ingrid⁵,Apelian David⁵,Koh Christopher⁶,Heller Theo⁶,Idilman Ramazan¹,Bozdayi A. Mithat²,Glenn Jeffrey S.⁷⁸

Affiliation:

1. Department of Gastroenterology University of Ankara Medical School Ankara Turkey

2. Hepatology Institute University of Ankara Ankara Turkey

3. Department of Gastroenterology and Hepatology Koç University Medical School Istanbul Turkey

4. Department of Medicine II Saarland University Medical Center Saarland University Homburg Germany

5. Eiger BioPharmaceuticals, Inc. Palo Alto California USA

6. Translational Hepatology Section Liver Diseases Branch National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health Bethesda Maryland USA

7. Departments of Medicine (Division of Gastroenterology and Hepatology) and Microbiology & Immunology Stanford School of Medicine Stanford California USA

8. Palo Alto Veterans Administration Palo Alto California USA

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32259

Reference21 articles.

1. Pathogenesis of and New Therapies for Hepatitis D

2. Treatment of Chronic Delta Hepatitis

3. Interferon Treatment Duration in Patients With Chronic Delta Hepatitis and its Effect on the Natural Course of the Disease

4. Identification of a Prenylation Site in Delta Virus Large Antigen

5. Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Forgotten Virus, Hepatitis D: A Review of Epidemiology, Diagnosis, and Current Treatment Strategies;Journal of Clinical and Experimental Hepatology;2024-09

2. Targeting NTCP for liver disease treatment: A promising strategy;Journal of Pharmaceutical Analysis;2024-09

3. Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives;International Journal of Pharmaceutics;2024-07

4. Hepatitis delta testing trends in a US national cohort: An analysis of patient and provider-level predictive factors;Hepatology Communications;2024-04-12

5. Prospects for Controlling Hepatitis B Globally;Pathogens;2024-03-29